Our Three Step Process

Our Three Step Process

The Development of the Rapid PCR Testing Tool: Revolutionizing Diagnostics for Visby Medical

Our Three Step Process

The Development of the Rapid PCR Testing Tool: Revolutionizing Diagnostics for Visby Medical

Amid the COVID-19 pandemic, Adam de la Zerda, founder of Visby Medical, partnered with NorthnStar to develop the Rapid PCR Testing Tool. This groundbreaking device delivers lab-accurate results in under 30 minutes, combining portability and precision for point-of-care diagnostics. The Rapid PCR Tool established Visby Medical as a global leader in healthcare innovation, transforming testing during a critical time.

Introduction: Transforming Diagnostics in a Pandemic

Amid the COVID-19 pandemic, Adam de la Zerda, founder of Visby Medical, sought to address the urgent need for accurate and rapid diagnostic tools. His vision was to create a portable PCR testing device that combined the accuracy of laboratory results with the speed and convenience required in high-pressure situations.

This vision led to the development of the Rapid PCR Testing Tool, a groundbreaking product that redefined diagnostic testing during the pandemic. Partnering with NorthnStar, Adam and Visby Medical turned this ambitious idea into a reality, positioning the company as a leader in cutting-edge medical technology while playing a crucial role in the global fight against COVID-19.

Challenges: Innovating Rapid Diagnostics

The development of the Rapid PCR Testing Tool presented significant challenges, especially under the time-sensitive conditions of a global pandemic:

  1. Speed and Accuracy: Developing a device that delivers laboratory-grade PCR results in under 30 minutes.

  2. Portability and Usability: Designing a compact, user-friendly tool suitable for point-of-care and remote testing environments.

  3. Adaptability: Ensuring the device could detect a wide range of respiratory pathogens, including SARS-CoV-2 and other viruses.

  4. Scalability: Creating a solution that could be manufactured and distributed quickly to meet global demand.

Process: Crafting the Rapid PCR Testing Tool

Discovery and Concept Development

NorthnStar’s Discovery Lab collaborated with Adam de la Zerda to identify the critical gaps in existing diagnostic solutions. Research highlighted the need for a portable, fast, and reliable PCR testing device that could empower healthcare providers and reduce reliance on centralized laboratories.

From these insights, the Rapid PCR Testing Tool was conceptualized as a compact, all-in-one device capable of providing highly accurate results in a fraction of the time required by traditional methods.

Engineering and Design

NorthnStar’s Design Lab focused on integrating advanced diagnostic technology with user-centric design. Key features include:

  • Fast and Accurate Testing: Delivers PCR results in under 30 minutes, maintaining the gold standard of diagnostic accuracy.

  • Compact and Portable: Designed for use in diverse settings, from hospitals and clinics to remote and resource-limited environments.

  • Easy-to-Use Interface: Intuitive controls and a simplified workflow, enabling use by healthcare professionals and trained non-experts.

  • Broad Detection Capability: Detects SARS-CoV-2 and other respiratory pathogens with a single, comprehensive test.

  • Scalable Manufacturing: Engineered for efficient production, enabling rapid deployment to meet global demand.

Prototyping and Testing

NorthnStar developed and tested multiple prototypes, focusing on performance, accuracy, and usability under real-world conditions. Feedback from healthcare providers and field testing during the pandemic informed refinements, ensuring the tool met the highest standards of reliability and effectiveness.

Market Strategy and Launch

The Rapid PCR Testing Tool was introduced during the COVID-19 pandemic as a breakthrough solution for decentralized testing. NorthnStar marketing strategy emphasized its speed, accuracy, and portability, highlighting its ability to save lives by enabling early detection and intervention.

Conclusion: Advancing Healthcare with Rapid PCR Testing

The Rapid PCR Testing Tool exemplifies the power of innovation in addressing global challenges. Through their collaboration with NorthnStar, Adam de la Zerda and Visby Medical developed a product that redefined diagnostic testing, empowering healthcare providers and improving outcomes during the COVID-19 pandemic.

This success underscores the potential of thoughtful design and cutting-edge technology to transform healthcare delivery. The Rapid PCR Testing Tool is not just a diagnostic device; it’s a testament to the role of innovation in saving lives and shaping the future of medicine.

Client Testimonial:
"The Rapid PCR Testing Tool has revolutionized diagnostics, empowering healthcare providers with speed and accuracy when it was needed most. NorthnStar’s expertise was essential in bringing this lifesaving product to life, and we’re proud to continue making an impact globally."
– Adam de la Zerda, Founder of Visby Medical

Introduction: Transforming Diagnostics in a Pandemic

Amid the COVID-19 pandemic, Adam de la Zerda, founder of Visby Medical, sought to address the urgent need for accurate and rapid diagnostic tools. His vision was to create a portable PCR testing device that combined the accuracy of laboratory results with the speed and convenience required in high-pressure situations.

This vision led to the development of the Rapid PCR Testing Tool, a groundbreaking product that redefined diagnostic testing during the pandemic. Partnering with NorthnStar, Adam and Visby Medical turned this ambitious idea into a reality, positioning the company as a leader in cutting-edge medical technology while playing a crucial role in the global fight against COVID-19.

Challenges: Innovating Rapid Diagnostics

The development of the Rapid PCR Testing Tool presented significant challenges, especially under the time-sensitive conditions of a global pandemic:

  1. Speed and Accuracy: Developing a device that delivers laboratory-grade PCR results in under 30 minutes.

  2. Portability and Usability: Designing a compact, user-friendly tool suitable for point-of-care and remote testing environments.

  3. Adaptability: Ensuring the device could detect a wide range of respiratory pathogens, including SARS-CoV-2 and other viruses.

  4. Scalability: Creating a solution that could be manufactured and distributed quickly to meet global demand.

Process: Crafting the Rapid PCR Testing Tool

Discovery and Concept Development

NorthnStar’s Discovery Lab collaborated with Adam de la Zerda to identify the critical gaps in existing diagnostic solutions. Research highlighted the need for a portable, fast, and reliable PCR testing device that could empower healthcare providers and reduce reliance on centralized laboratories.

From these insights, the Rapid PCR Testing Tool was conceptualized as a compact, all-in-one device capable of providing highly accurate results in a fraction of the time required by traditional methods.

Engineering and Design

NorthnStar’s Design Lab focused on integrating advanced diagnostic technology with user-centric design. Key features include:

  • Fast and Accurate Testing: Delivers PCR results in under 30 minutes, maintaining the gold standard of diagnostic accuracy.

  • Compact and Portable: Designed for use in diverse settings, from hospitals and clinics to remote and resource-limited environments.

  • Easy-to-Use Interface: Intuitive controls and a simplified workflow, enabling use by healthcare professionals and trained non-experts.

  • Broad Detection Capability: Detects SARS-CoV-2 and other respiratory pathogens with a single, comprehensive test.

  • Scalable Manufacturing: Engineered for efficient production, enabling rapid deployment to meet global demand.

Prototyping and Testing

NorthnStar developed and tested multiple prototypes, focusing on performance, accuracy, and usability under real-world conditions. Feedback from healthcare providers and field testing during the pandemic informed refinements, ensuring the tool met the highest standards of reliability and effectiveness.

Market Strategy and Launch

The Rapid PCR Testing Tool was introduced during the COVID-19 pandemic as a breakthrough solution for decentralized testing. NorthnStar marketing strategy emphasized its speed, accuracy, and portability, highlighting its ability to save lives by enabling early detection and intervention.

Conclusion: Advancing Healthcare with Rapid PCR Testing

The Rapid PCR Testing Tool exemplifies the power of innovation in addressing global challenges. Through their collaboration with NorthnStar, Adam de la Zerda and Visby Medical developed a product that redefined diagnostic testing, empowering healthcare providers and improving outcomes during the COVID-19 pandemic.

This success underscores the potential of thoughtful design and cutting-edge technology to transform healthcare delivery. The Rapid PCR Testing Tool is not just a diagnostic device; it’s a testament to the role of innovation in saving lives and shaping the future of medicine.

Client Testimonial:
"The Rapid PCR Testing Tool has revolutionized diagnostics, empowering healthcare providers with speed and accuracy when it was needed most. NorthnStar’s expertise was essential in bringing this lifesaving product to life, and we’re proud to continue making an impact globally."
– Adam de la Zerda, Founder of Visby Medical

Join our newsletter list

Sign up to get the most recent blog articles in your email every week.

Share this post to the social medias

Amid the COVID-19 pandemic, Adam de la Zerda, founder of Visby Medical, partnered with NorthnStar to develop the Rapid PCR Testing Tool. This groundbreaking device delivers lab-accurate results in under 30 minutes, combining portability and precision for point-of-care diagnostics. The Rapid PCR Tool established Visby Medical as a global leader in healthcare innovation, transforming testing during a critical time.

Introduction: Transforming Diagnostics in a Pandemic

Amid the COVID-19 pandemic, Adam de la Zerda, founder of Visby Medical, sought to address the urgent need for accurate and rapid diagnostic tools. His vision was to create a portable PCR testing device that combined the accuracy of laboratory results with the speed and convenience required in high-pressure situations.

This vision led to the development of the Rapid PCR Testing Tool, a groundbreaking product that redefined diagnostic testing during the pandemic. Partnering with NorthnStar, Adam and Visby Medical turned this ambitious idea into a reality, positioning the company as a leader in cutting-edge medical technology while playing a crucial role in the global fight against COVID-19.

Challenges: Innovating Rapid Diagnostics

The development of the Rapid PCR Testing Tool presented significant challenges, especially under the time-sensitive conditions of a global pandemic:

  1. Speed and Accuracy: Developing a device that delivers laboratory-grade PCR results in under 30 minutes.

  2. Portability and Usability: Designing a compact, user-friendly tool suitable for point-of-care and remote testing environments.

  3. Adaptability: Ensuring the device could detect a wide range of respiratory pathogens, including SARS-CoV-2 and other viruses.

  4. Scalability: Creating a solution that could be manufactured and distributed quickly to meet global demand.

Process: Crafting the Rapid PCR Testing Tool

Discovery and Concept Development

NorthnStar’s Discovery Lab collaborated with Adam de la Zerda to identify the critical gaps in existing diagnostic solutions. Research highlighted the need for a portable, fast, and reliable PCR testing device that could empower healthcare providers and reduce reliance on centralized laboratories.

From these insights, the Rapid PCR Testing Tool was conceptualized as a compact, all-in-one device capable of providing highly accurate results in a fraction of the time required by traditional methods.

Engineering and Design

NorthnStar’s Design Lab focused on integrating advanced diagnostic technology with user-centric design. Key features include:

  • Fast and Accurate Testing: Delivers PCR results in under 30 minutes, maintaining the gold standard of diagnostic accuracy.

  • Compact and Portable: Designed for use in diverse settings, from hospitals and clinics to remote and resource-limited environments.

  • Easy-to-Use Interface: Intuitive controls and a simplified workflow, enabling use by healthcare professionals and trained non-experts.

  • Broad Detection Capability: Detects SARS-CoV-2 and other respiratory pathogens with a single, comprehensive test.

  • Scalable Manufacturing: Engineered for efficient production, enabling rapid deployment to meet global demand.

Prototyping and Testing

NorthnStar developed and tested multiple prototypes, focusing on performance, accuracy, and usability under real-world conditions. Feedback from healthcare providers and field testing during the pandemic informed refinements, ensuring the tool met the highest standards of reliability and effectiveness.

Market Strategy and Launch

The Rapid PCR Testing Tool was introduced during the COVID-19 pandemic as a breakthrough solution for decentralized testing. NorthnStar marketing strategy emphasized its speed, accuracy, and portability, highlighting its ability to save lives by enabling early detection and intervention.

Conclusion: Advancing Healthcare with Rapid PCR Testing

The Rapid PCR Testing Tool exemplifies the power of innovation in addressing global challenges. Through their collaboration with NorthnStar, Adam de la Zerda and Visby Medical developed a product that redefined diagnostic testing, empowering healthcare providers and improving outcomes during the COVID-19 pandemic.

This success underscores the potential of thoughtful design and cutting-edge technology to transform healthcare delivery. The Rapid PCR Testing Tool is not just a diagnostic device; it’s a testament to the role of innovation in saving lives and shaping the future of medicine.

Client Testimonial:
"The Rapid PCR Testing Tool has revolutionized diagnostics, empowering healthcare providers with speed and accuracy when it was needed most. NorthnStar’s expertise was essential in bringing this lifesaving product to life, and we’re proud to continue making an impact globally."
– Adam de la Zerda, Founder of Visby Medical

Join our newsletter list

Sign up to get the most recent blog articles in your email every week.

Share this post to the social medias

Other Projects

Other Case Studies

Check our other project case studies with detailed explanations

Other Projects

Other Case Studies

Check our other project case studies with detailed explanations